← ToolkitPublished changes
Owner-requested Pediatric Vaccines refinement: explicit qualifying-condition versus routine/shared-decision recommendations, vaccine-specific age-aware catch-up intervals and age limits, and concrete second-season RSV eligibility. Documented dose dates remain necessary to select a catch-up branch.2026-11-07 · Suggestion #17
Verification sourceAdditional verification source
Owner-approved Pediatric Vaccines cumulative history: all routine series started by the entered age remain visible, including infant series in adolescents; product-dependent counts, open dose windows, brand examples, schedule exceptions, explicit upcoming doses and separate seasonal/risk-based immunizations. Age-only expectations do not assert recorded receipt or generate individual catch-up doses.2026-11-07 · Suggestion #17
Verification sourceAdditional verification source
Additional verification source
Owner-requested CrCl update: blank serum creatinine allows a BMI-only result from age, height and weight; no creatinine clearance is generated. Existing renal calculation remains available with valid creatinine.2026-11-02 · Suggestion #undefined
Verification sourceExpanded Pediatric Vaccine Screening’s nested guidance with CDC-listed brand examples for the current and next age checkpoints, pediatric combination products, and a VFC category indicator. Added a VFC category overview and child/provider eligibility criteria. Brand examples do not represent local stock; eligibility is not inferred from age and weight.2026-10-21 · Suggestion #undefined
Verification sourceAdditional verification source
Additional verification source
Additional verification source
Refined Pediatric Vaccine Screening: age uses a months checkbox, input fields align cleanly, and supplementary vaccine details are nested. First-season RSV infant guidance now assumes maternal RSV vaccination was not given and displays nirsevimab weight-based doses or clesrovimab 105 mg; second-season nirsevimab remains limited to children meeting CDC increased-risk criteria. Pregnancy & Lactation and Pediatric Vaccines are top-level Clinical Tools in the sidebar; Respiratory remains nested under Clinical Reference.2026-10-21 · Suggestion #undefined
Verification sourceAdditional verification source
Additional verification source
Added Pediatric Vaccine Screening as an individual Clinical Reference tool. Age and optional weight generate a printable age-window checklist with pediatric vaccine brand examples, annual influenza and current-season COVID-19 review, and conditional infant RSV product logic. No patient identifiers or vaccine history are collected or saved; age alone does not determine whether a dose is due.2026-10-21 · Suggestion #13
Verification sourceAdditional verification source
Additional verification source
Additional verification source
Additional verification source
Additional verification source
Added a compact BMI result box to the CrCl calculator, reusing its measured height and weight. Adult BMI categories display only from age 20; ages 18–19 receive a prompt for sex- and age-specific BMI-for-age interpretation. Includes screening-only note.2026-10-11 · Suggestion #10
Verification sourceAdditional verification source
Draft renal/hepatic lookup entry for amlodipine: label states renal impairment does not significantly affect pharmacokinetics and usual initial dose may be used; hepatic insufficiency may start at 2.5 mg daily and severe hepatic impairment requires slow titration. No Child-Pugh-specific recommendation inferred.2026-10-11 · Suggestion #5
Verification sourceDraft thiamine IV-direct administration note for the stocked 200 mg/2 mL (100 mg/mL) product: CHEO describes usual dilution to 10 mg/mL and administration over 1–2 minutes; DailyMed labeling warns of serious hypersensitivity/anaphylaxis and says administer slowly for wet beriberi with myocardial failure. Existing intermittent infusion options remain separate.2026-10-11 · Suggestion #11
Verification sourceAdditional verification source
Closed as already present: the reference contains stocked IV diltiazem products, search aliases, administration guidance, and a DailyMed citation. No additional diltiazem content was needed.2026-10-11 · Suggestion #1
Verification sourceOwner-approved adult Infectious Diseases module: green interface with syndrome, organism and stocked-antibiotic views; eight initial pathways; 2025 ZSU antibiogram; 28 inventory-listed injectable agents; culture interpretation and conditional oral transition. Small-sample/specimen limitations and source discrepancy are explicit. Oral stock is unconfirmed until checked in-session. Existing tools and training manual preserved.2026-10-10 · Suggestion #undefined
Verification sourceAdditional verification source
Additional verification source
Additional verification source
Owner-approved Briggs 12th-edition expansion: 1,402 unique searchable catalog entries, including class monographs, source cross-references and historical notices. Original 20 entries have edition-specific summary comparison notes and newer citations. Additional 1,382 records show imported historical assessments and current review pending, without invented trimester ratings or gestational thresholds. EPUB and monograph prose are not hosted.2026-10-10 · Suggestion #9
Verification sourceOwner-approved Pregnancy & Breastfeeding reference under Clinical reference: 20 searchable medication entries, four trimester/lactation cards, public source citations and check dates, optional gestational-week flags for NSAIDs and nitrofurantoin. Briggs explicitly not yet verified. Existing case tools and training manual retained.2026-10-10 · Suggestion #9
Verification sourceAdditional verification source
Additional verification source
Owner-approved presentation refinement: acetaminophen age/product note also shown as plain reference text without the colored highlight; header and page title display Version 18. Dose calculations and cap alerts unchanged.2026-10-10 · Suggestion #undefined
Verification sourceOwner-approved presentation refinement: ibuprofen OTC consultation note shown as plain reference text instead of a highlighted box; toolkit header and page title display Version 17. Dosing calculations and safety caps unchanged.2026-10-10 · Suggestion #undefined
Verification sourceOwner-approved pediatric interface refinement: conditional ≥40 kg weight-review guidance; separate prominent per-dose and daily cap messages; automatic pediatric IBW estimate using bundled CDC age/sex BMI50 × height² for ages 2–17, height in cm/in and manual verified-IBW option. IBW explicitly selected, never inferred from the weight trigger; existing medication dose ceilings retained.2026-10-10 · Suggestion #undefined
Verification sourceAdditional verification source
Additional verification source
Owner-approved pediatric age/weight guidance update: pharmacist recommendation output; explicit measured-weight/PPA or verified pediatric IBW/RCH acetaminophen approach (60 mg/kg/day for IBW); existing 1,000 mg acetaminophen and 400 mg ibuprofen fever/pain caps retained; age/formulation warnings and ≥40 kg/ceiling explanations added. No automatic IBW estimation or universal under-12 acetaminophen cap.2026-10-10 · Suggestion #8
Verification sourceAdditional verification source
Additional verification source
Additional verification source
Additional verification source
Owner-approved pediatric age/weight guidance update: pharmacist recommendation output; explicit measured-weight/PPA or verified pediatric IBW/RCH acetaminophen approach (60 mg/kg/day for IBW); existing 1,000 mg acetaminophen and 400 mg ibuprofen fever/pain caps retained; age/formulation warnings and ≥40 kg/ceiling explanations added. No automatic IBW estimation or universal under-12 acetaminophen cap.2026-10-10 · Suggestion #7
Verification sourceAdditional verification source
Additional verification source
Additional verification source
Additional verification source
Owner-approved pediatric age/weight guidance update: pharmacist recommendation output; explicit measured-weight/PPA or verified pediatric IBW/RCH acetaminophen approach (60 mg/kg/day for IBW); existing 1,000 mg acetaminophen and 400 mg ibuprofen fever/pain caps retained; age/formulation warnings and ≥40 kg/ceiling explanations added. No automatic IBW estimation or universal under-12 acetaminophen cap.2026-10-10 · Suggestion #6
Verification sourceAdditional verification source
Additional verification source
Additional verification source
Additional verification source
Owner-approved methylprednisolone sodium succinate IV infusion update: dose-based 30–60 minutes above 250 mg, 60 minutes at ≥500 mg or ≥10 mg/kg (including 1000 mg); FDA label minimum distinguished from hospital guidance. All four existing strength rows updated; stock, dilutions and BUD retained.2026-10-06 · Suggestion #2
Verification sourceAdditional verification source
Owner-requested pediatric oral acetaminophen/ibuprofen dose tool added with kg/lb conversion, liquid concentrations, mg/mL results, age restrictions, dose caps and rolling 24-hour limits.2026-10-06 · Owner-requested update
Verification sourceAdditional verification source
Additional verification source
Additional verification source
Owner-requested pediatric tool refinement: pink palette; acetaminophen 325 mg tablets and 80/160 mg chewables; ibuprofen 200 mg tablets and 100 mg chewables. Shows unrounded tablet equivalents with formulation-specific age and product-label cautions; clinical dose limits retained.2026-10-06 · Owner-requested update
Verification sourceAdditional verification source
Additional verification source
Additional verification source
Additional verification source
Owner-approved Pediatric Illness QuickDoser: five-medication selector; oseltamivir treatment/prevention with infant guideline and renal/prematurity guards; product-specific guaifenesin/dextromethorphan with both ingredient limits; initial single-dose off-label gastroenteritis ondansetron with liquid/tablet/ODT conversions and QT/apomorphine guards. Existing acetaminophen/ibuprofen calculations and pink palette retained.2026-10-06 · Owner-requested update
Verification sourceAdditional verification source
Additional verification source
Additional verification source
Additional verification source
Owner-requested Respiratory Surveillance module: live CDC COVID-19, influenza A and RSV wastewater readings; McKinley-serving sites with labeled NM/West/national fallbacks, matched-site trends, underlying values, national clinical positivity and 12-hour refresh with last-known-good caching. No patient data or clinical guidance changed.2026-10-06 · Owner-requested update
Verification sourceAdditional verification source
Additional verification source
Additional verification source
Fixed Respiratory Surveillance toolbar icon: render the existing trusted SVG instead of displaying its markup as green text. Existing data, calculations and modules preserved.2026-10-06 · Owner-requested update
Verification sourceMoved Respiratory Surveillance into a collapsible Clinical reference sidebar section. Case tools remain at the top level; selecting Respiratory directly expands its group.2026-10-06 · Owner-requested update
Verification source